Elective Discontinuation of Checkpoint Inhibitor Therapy in Patients with advanced Melanoma

被引：0
|
作者：
Persa, O. D. [1 ]
Schatton, K. [1 ]
Ruebben, A. [2 ]
Berking, C. [3 ]
Erdmann, M. [3 ]
Schlaak, M. [4 ]
Mauch, C. [5 ]
Steeb, T. [3 ]
机构：
[1] Uniklin Dusseldorf, Dusseldorf, Germany
[2] Uniklin Aachen, Aachen, Germany
[3] Uniklin Erlangen, Erlangen, Germany
[4] Charite Univ Med Berlin, Berlin, Germany
[5] Uniklin Koln, Cologne, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2021年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP 018
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [21] BRAF inhibitor discontinuation and rechallenge in advanced melanoma patients with a complete initial treatment response
    Desvignes, Celine
    Rached, Henry Abi
    Templier, Carole
    Drumez, Elodie
    Lepesant, Pauline
    Desmedt, Eve
    Mortier, Laurent
    MELANOMA RESEARCH, 2017, 27 (03) : 281 - 287
  • [22] Survivals following discontinuation of PD-1 inhibitor treatment in advanced melanoma patients
    Kartolo, Adi
    Tong, Justin
    Yeung, Cynthia
    Kuksis, Markus
    Hopman, Wilma
    Baetz, Tara
    MELANOMA RESEARCH, 2023, 33 (01) : 50 - 57
  • [23] Acute Myocarditis After Discontinuation of Immune Checkpoint Inhibitor Therapy
    Tamura, Yudai
    Tamura, Yuichi
    Taniguchi, Hirohisa
    Imanaka-Yoshida, Kyoko
    CIRCULATION JOURNAL, 2023, 87 (02)
  • [24] OUTCOME OF PLANNED CHECKPOINT INHIBITOR DISCONTINUATION IN METASTATIC MELANOMA PATIENTS IN A COMMUNITY ONCOLOGY PRACTICE: A CASE SERIES
    Perez, L.
    Samlowski, W.
    Lopez-Flores, R. D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 262 - 262
  • [25] Optimal Duration of Maintenance Checkpoint Inhibitor Therapy in Patients With Advanced NSCLC
    Shukla, Nikhil
    Hanna, Nasser
    Durm, Greg
    JCO ONCOLOGY PRACTICE, 2021, 17 (08) : 472 - +
  • [26] Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients
    Biewenga, Maaike
    van der Kooij, Monique K.
    Wouters, Michel W. J. M.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    de Groot, Jan Willem B.
    Boers-Sonderen, Marye J.
    Hospers, Geke A. P.
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Suijkerbuijk, Karijn P. M.
    ten Tije, Albert J.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Haanen, John B. A. G.
    van der Eertwegh, Alfons J. M.
    van Hoek, Bart
    Kapiteijn, Ellen
    HEPATOLOGY INTERNATIONAL, 2021, 15 (02) : 510 - 519
  • [27] Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients
    Maaike Biewenga
    Monique K. van der Kooij
    Michel W. J. M. Wouters
    Maureen J. B. Aarts
    Franchette W. P. J. van den Berkmortel
    Jan Willem B. de Groot
    Marye J. Boers-Sonderen
    Geke A. P. Hospers
    Djura Piersma
    Rozemarijn S. van Rijn
    Karijn P. M. Suijkerbuijk
    Albert J. ten Tije
    Astrid A. M. van der Veldt
    Gerard Vreugdenhil
    John B. A. G. Haanen
    Alfons J. M. van der Eertwegh
    Bart van Hoek
    Ellen Kapiteijn
    Hepatology International, 2021, 15 : 510 - 519
  • [28] Advanced Research on Immune Checkpoint Inhibitor Therapy
    Imai, Hisao
    Kaira, Kyoichi
    Kagamu, Hiroshi
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [29] Immune checkpoint inhibitor treatment of advanced age metastatic melanoma (MM) patients.
    Hegde, Upendra P.
    Kerr, Phil
    Masternak, Sophie
    Brenner, Bruce Mark
    Grant-Kels, Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma
    Hong, Bennett Yau-Bun
    Ford, Joshua R.
    Glitza, Isabella C.
    Cabala, Carlos A. Torres
    Tetzlaff, Michael
    Prieto, Victor G.
    Parker, Richard
    Daniel, Claire
    Esmaeli, Bita
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (01): : E9 - E13
12345